Medpace Holdings Return on Equity

Medpace Holdings (MEDP) currently reports a ROE of 113.29%. That is above the Healthcare sector average of 22.01%. Use the charts on this page to explore Medpace Holdings's ROE history and peer comparisons.

Medpace Holdings's ROE of 113.29% is higher than the Healthcare sector average of 22.01%. That is roughly 414.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Medpace Holdings's current 113.29% should be judged against Healthcare norms (sector average: 22.01%) and against MEDP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 113.29%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Medpace Holdings, and consider following MEDP for alerts when major investors trade the stock.

Medpace Holdings is classified in the Healthcare sector. On ROE, it currently shows 113.29% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MEDP with unrelated industries.